Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Satchell, S. C.
Right arrow Articles by Mathieson, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Satchell, S. C.
Right arrow Articles by Mathieson, P. W.
J Am Soc Nephrol 15:566-574, 2004
© 2004 American Society of Nephrology


BASIC SCIENCE

Angiopoietin 1 and Vascular Endothelial Growth Factor Modulate Human Glomerular Endothelial Cell Barrier Properties

Simon C. Satchell, Karen L. Anderson and Peter W. Mathieson

Academic Renal Unit, University of Bristol, Southmead Hospital, Bristol, United Kingdom

Correspondence to Dr. Simon Satchell, Academic Renal Unit, University of Bristol, Southmead Hospital, Bristol, BS10 5NB, UK. Phone: +44-117-959-5437; Fax: +44-117-959-5438; E-mail s.c.satchell{at}bris.ac.uk

ABSTRACT. Normal glomerular filtration depends on the combined properties of the three layers of glomerular capillary wall: glomerular endothelial cells (GEnC), basement membrane, and podocytes. Podocytes produce endothelial factors, including angiopoietin 1 (ang1), and vascular endothelial growth factor (VEGF), whereas GEnC express their respective receptors Tie2 and VEGFR2 in vivo. As ang1 acts to maintain the endothelium in other vascular beds, regulating some actions of VEGF, these observations suggest a mechanism whereby podocytes may direct the unique properties of the glomerular endothelium. This interaction was investigated by studies on the barrier properties of human GEnC in vitro. GEnC were examined for expression of endothelium-specific markers by immunofluorescence and Western blotting and for typical responses to TNF-{alpha} by a cell-based immunoassay. Expression of angiopoietin and VEGF receptors was examined similarly. Barrier properties of GEnC monolayers cultured on porous supports were investigated by measurement of transendothelial electrical resistance (TEER) and passage of labeled albumin. Responses to a cAMP analogue and thrombin were examined before those to ang1 and VEGF. Results confirmed the endothelial origin of GEnC and their expression of Tie2 and VEGFR2. GEnC formed monolayers with a mean TEER of 30 to 40 {Omega}/cm2. The cAMP analogue and thrombin increased and decreased TEER by 34.4 and 14.8 {Omega}/cm2, respectively, with corresponding effects on protein passage. Ang1 increased TEER by 11.4 {Omega}/cm2 and reduced protein passage by 45.2%, whereas VEGF reduced TEER by 12.5 {Omega}/cm2 but had no effect on protein passage. Both ang1 and VEGF modulate GEnC barrier properties, consistent with potential in vivo roles; ang1 stabilizing the endothelium and resisting angiogenesis while VEGF induces the high permeability to water, characteristic of the glomerular endothelium.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. Lennon, A. Singh, G. I. Welsh, R. J. Coward, S. Satchell, L. Ni, P. W. Mathieson, W. W. Bakker, and M. A. Saleem
Hemopexin Induces Nephrin-Dependent Reorganization of the Actin Cytoskeleton in Podocytes
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2140 - 2149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. R. Foster, S. C. Slater, J. Seckley, D. Kerjaschki, D. O. Bates, P. W. Mathieson, and S. C. Satchell
Vascular Endothelial Growth Factor-C, a Potential Paracrine Regulator of Glomerular Permeability, Increases Glomerular Endothelial Cell Monolayer Integrity and Intracellular Calcium
Am. J. Pathol., October 1, 2008; 173(4): 938 - 948.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. N. Gavrilovskaya, E. E. Gorbunova, N. A. Mackow, and E. R. Mackow
Hantaviruses Direct Endothelial Cell Permeability by Sensitizing Cells to the Vascular Permeability Factor VEGF, while Angiopoietin 1 and Sphingosine 1-Phosphate Inhibit Hantavirus-Directed Permeability
J. Virol., June 15, 2008; 82(12): 5797 - 5806.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. E. Quaggin and J. A. Kreidberg
Development of the renal glomerulus: good neighbors and good fences
Development, February 15, 2008; 135(4): 609 - 620.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. C. Satchell, O. Buchatska, S. B. Khan, G. Bhangal, C. H. Tasman, M. A. Saleem, D. P. Baker, R. R. Lobb, J. Smith, H. T. Cook, et al.
Interferon-beta Reduces Proteinuria in Experimental Glomerulonephritis
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2875 - 2884.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Singh, S. C. Satchell, C. R. Neal, E. A. McKenzie, J. E. Tooke, and P. W. Mathieson
Glomerular Endothelial Glycocalyx Constitutes a Barrier to Protein Permeability
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2885 - 2893.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. J. Rees and R. Kain
Interferon-beta: A Novel Way to Treat Nephrotic Syndrome?
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2797 - 2798.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Davis, A. Dei Cas, D. A. Long, K. E. White, A. Hayward, C.-H. Ku, A. S. Woolf, R. Bilous, G. Viberti, and L. Gnudi
Podocyte-Specific Expression of Angiopoietin-2 Causes Proteinuria and Apoptosis of Glomerular Endothelia
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2320 - 2329.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Amann, C. Wanner, and E. Ritz
Cross-Talk between the Kidney and the Cardiovascular System
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2112 - 2119.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. R. Foster, S. C. Satchell, J. Seckley, M. S. Emmett, K. Joory, C. Y. Xing, M. A. Saleem, P. W. Mathieson, D. O. Bates, and S. J. Harper
VEGF-C promotes survival in podocytes
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F196 - F207.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Roestenberg, F. A. van Nieuwenhoven, J. A. Joles, C. Trischberger, P. P. Martens, N. Oliver, J. Aten, J. W. Hoppener, and R. Goldschmeding
Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice
Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1344 - F1354.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. P.J. Brindle, P. Saharinen, and K. Alitalo
Signaling and Functions of Angiopoietin-1 in Vascular Protection
Circ. Res., April 28, 2006; 98(8): 1014 - 1023.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Salmon, D. Bates, and S. Harper
Blockade Of Endogenous Vascular Endothelial Growth Factor (VEGF) Reveals A Role For Endothelium In The Regulation Of Mammalian Glomerular Permeability
FASEB J, March 1, 2006; 20(4): A763 - A763.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
P. W. Mathieson
How Much VEGF Do You Need?
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 602 - 603.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Zent and A. Pozzi
Antiangiogenic Therapy in Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 325 - 327.
[Full Text] [PDF]


Home page
J. Physiol.Home page
A. H. J. Salmon, C. R. Neal, D. O. Bates, and S. J. Harper
Vascular endothelial growth factor increases the ultrafiltration coefficient in isolated intact Wistar rat glomeruli
J. Physiol., January 1, 2006; 570(1): 141 - 156.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Baffert, T. Le, G. Thurston, and D. M. McDonald
Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H107 - H118.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. W, Y. PX, L. BM, C. RD, M. DL, M. RH, I. H, O. MH, W. K, B.-J. K, et al.
Anorexia and Cachexia in Renal Failure--Is Leptin the Culprit?: Role of Leptin and Melanocortin Signaling in Uremia-Associated Cachexia. J Clin Invest 115: 1659-1665, 2005
J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2245 - 2250.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Togel, Z. Hu, K. Weiss, J. Isaac, C. Lange, C. Westenfelder, T. Stasko, M.D. Brown, J.A. Carucci, S. Euvrard, et al.
Amelioration of Acute Renal Failure by Stem Cell Therapy--Paracrine Secretion Versus Transdifferentiation into Resident Cells: Administered Mesenchymal Stem Cells Protect against Ischemic Acute Renal Failure through Differentiation-Independent Mechanisms. Am J Physiol Renal Physiol E-pub February 15, 2005
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1153 - 1163.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP